Expression of ERCC1 and class III β-tubulin is associated with the survival of resected stage III non-small cell lung cancer patients treated with induction chemoradiotherapy using carboplatin-taxane.
暂无分享,去创建一个
M. Ueno | K. Kadota | S. Chang | H. Yokomise | Noriyuki Misaki | S. Ishikawa | Dage Liu | M. Gotoh | Cheng‐long Huang | N. Nakasima